An2 Therapeutics shares owned by Captrust Financial Advisors
Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Captrust Financial Advisors
from 13F filings
Historical chart of Captrust Financial Advisors investment in An2 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including An2 Therapeutics held by Captrust Financial Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in An2 Therapeutics by Captrust Financial Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $51k | 40k | 1.27 |
| 2025-06-30 | $42k | 40k | 1.06 |
| 2025-03-31 | $14k | 10k | 1.36 |
| 2024-12-31 | $40k | 29k | 1.38 |
| 2024-09-30 | $31k | 29k | 1.07 |
| 2024-06-30 | $62k | 29k | 2.15 |
| 2024-03-31 | $93k | 29k | 3.25 |
| 2023-12-31 | $587k | 29k | 20.49 |
| 2023-09-30 | $461k | 29k | 16.08 |
More positions owned by Captrust Financial Advisors
View all positions for Captrust Financial Advisors